Differential effects of vasodilatory prostaglandins on focal adhesions, cytoskeletal architecture, and migration in human aortic smooth muscle cells

被引:39
作者
Bulin, C
Albrecht, U
Bode, JG
Weber, AA
Schrör, K
Levkau, B
Fischer, JW
机构
[1] Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, D-4000 Dusseldorf, Germany
[3] Univ Essen Gesamthsch Klinikum, Inst Pathophysiol, D-4300 Essen, Germany
关键词
focal adhesion kinase; extracellular matrix; prostaglandins; atherosclerosis;
D O I
10.1161/01.ATV.0000146814.81581.68
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Cyclooxygenases 1 and 2 are expressed in atherosclerotic arteries, and local generation of prostacyclin and prostaglandin E-2 (PGE(2)) occurs. However, the role of cyclooxygenases and individual prostaglandins during plaque progression is currently uncertain. The present study characterizes the effect of vasodilatory prostaglandins on morphology, focal adhesion (FA) function, and migration in human aortic smooth muscle cells (SMCs). Methods and Results - The stable prostacyclin analog iloprost transiently induced: (1) disassembly of FA and stress fibers, (2) partial retraction and rounding of SMCs, (3) hypophosphorylation of FA kinase (FAK) and paxillin, and (4) inhibition of platelet-derived growth factor-BB- induced migration. Inhibition of FAK phosphorylation and morphological changes were mimicked by forskolin, inhibited by H89, and prevented by the protein tyrosine phosphatase inhibitor vanadate and by calpeptin. PGE(2) was by far less efficient with respect to all parameters investigated. This difference correlated with the respective cAMP induction in response to iloprost and PGE(2). Conclusion - Inhibition of FAK phosphorylation and FA function is a new target of vasodilatory prostaglandins, which might be causally involved in the antimigratory effects of prostaglandins. Importantly, prostacyclin analogs and PGE(2) differ dramatically with respect to dephosphorylation of FAK and inhibition of migration, which might be of relevance for their respective functions in atherosclerosis.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 33 条
[1]  
Aplin AE, 1998, PHARMACOL REV, V50, P197
[2]  
Belton O, 2000, CIRCULATION, V102, P840
[3]   Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes [J].
Bordin, L ;
Brunati, AM ;
Donella-Deana, A ;
Baggio, B ;
Toninello, A ;
Clari, G .
BLOOD, 2002, 100 (01) :276-282
[4]   Role of prostacyclin in the cardiovascular response to thromboxane A2 [J].
Cheng, Y ;
Austin, SC ;
Rocca, B ;
Koller, BH ;
Coffman, TM ;
Grosser, T ;
Lawson, JA ;
FitzGerald, GA .
SCIENCE, 2002, 296 (5567) :539-541
[5]   Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability [J].
Cipollone, F ;
Prontera, C ;
Pini, B ;
Marini, M ;
Fazia, M ;
De Cesare, D ;
Iezzi, A ;
Ucchino, S ;
Boccoli, G ;
Saba, V ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2001, 104 (08) :921-927
[6]   A NOVEL INHIBITORY PROSTANOID RECEPTOR IN PIGLET SAPHENOUS-VEIN [J].
COLEMAN, RA ;
GRIX, SP ;
HEAD, SA ;
LOUTTIT, JB ;
MALLETT, A ;
SHELDRICK, RLG .
PROSTAGLANDINS, 1994, 47 (02) :151-168
[7]  
COLEMAN RA, 1994, PHARMACOL REV, V46, P205
[8]   PROSTAGLANDIN-E RECEPTOR SUBTYPES IN SMOOTH-MUSCLE - AGONIST ACTIVITIES OF STABLE PROSTACYCLIN ANALOGS [J].
DONG, YJ ;
JONES, RL ;
WILSON, NH .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (01) :97-107
[9]   Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies [J].
Dzau, VJ ;
Braun-Dullaeus, RC ;
Sedding, DG .
NATURE MEDICINE, 2002, 8 (11) :1249-1256
[10]   HUMAN PLATELET ERYTHROLEUKEMIA CELL PROSTAGLANDIN G/H SYNTHASE - CDNA CLONING, EXPRESSION, AND GENE CHROMOSOMAL ASSIGNMENT [J].
FUNK, CD ;
FUNK, LB ;
KENNEDY, ME ;
PONG, AS ;
FITZGERALD, GA .
FASEB JOURNAL, 1991, 5 (09) :2304-2312